Safety and benefit of iron supplementation in HIV infected childre

Completed

• Conditions: HIV and iron deficiency; Infections and Infestations; Unspecified human immunodeficiency virus [HIV] disease

• Registration Number: ISRCTN62947977
• Lead Sponsor: iverpool School of Tropical Medicine (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2008-09-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1260

Inclusion Criteria

1. Both males and females, age 6-59 months
2. Presence of moderate anaemia (haemoglobin 7-9.9 g/dl)
3. HIV positive
4. Mean corpuscular volume (MCV) <=73 f/l (for children from 2-5 years); <=67 f/l (for children <2 years)
5. Informed consent by parent/guardian

Exclusion Criteria

1. Patients already on nutritional supplements
2. Presence of gross congenital, cognitive or neuro-developmental anomalies
3. Children with malnutrition requiring supplementary feeding; weight-for-height less than 80% of expected; presence of bipedal oedema
4. Patients with haemoglobin <7 g/dl or >=10 g/dl

Study & Design

• Study Type: Interventional
• Study Design: Not specified